$118.986,00
10% de descuento pagando con Transferencia o depósito
Ver más detalles
Descripcion
Indice
Autores
Muestra
Ficha Técnica
Descripción

A brand-new title in the field of dermatology, Therapy for Severe Psoriasis provides the ultimate coverage of the treatment options available for today's most serious cases, including biologics and oral therapies. It features discussions of the newest drug therapies, recent FDA-approved biosimilars, and combination approaches to care, while an overview chapter was designed to aid those new to the field in understanding the nuances of difficult-to-treat subtypes of psoriasis. Comprehensive and focused, Therapy for Severe Psoriasis will be a welcome addition to the library of any dermatologist seeking in-depth information on the challenges of this condition.

  • Each of the 16 chapters includes either an in-depth focus on a single therapy or an overview of a unique aspect of psoriasis, including: UVB therapy, methotrexate, acitretin, cyclosporine, apremilast, etanercept, infliximab, adalimumab, ustekinumab, secukinumab, and ixekizumab.
  • Takes an evidence-based approach to hard-to-treat severe psoriasis.
  • Discusses the newest drug therapies (such as ixekizumab), plus recent FDA-approved biosimilars, a topic unique to this particular psoriasis text.
  • Presents combination approaches for instances when standard treatments are not successful.
  • Includes an overview chapter to help beginners understand the nuances of the disorder.

1. Cover image - p. ii 2. Title page - p. ii 3. Table of Contents - p. iii 4. Copyright - p. iii 5. Contributors - p. iii 6. Foreword - p. iii 7. Preface - p. iii 8. List of Tables - p. iii 9. Chapter 1: Overview of Psoriasis - p. iii 10. Chapter 2: Ultraviolet B Phototherapy - p. 13 11. Chapter 3: Psoralen-Ultraviolet Light A Therapy - p. 24 12. Chapter 4: Methotrexate - p. 33 13. Chapter 5: Acitretin - p. 46 14. Chapter 6: Cyclosporine - p. 60 15. Chapter 7: Apremilast - p. 71 16. Chapter 8: Etanercept - p. 81 17. Chapter 9: Infliximab - p. 94 18. Chapter 10: Adalimumab - p. 107 19. Chapter 11: Ustekinumab - p. 124 20. Chapter 12: Secukinumab - p. 134 21. Chapter 13: Ixekizumab - p. 150 22. Chapter 14: Biosimilars - p. 161 23. Chapter 15: Combination Therapies for Psoriasis - p. 168 24. Chapter 16: Investigational Therapies for Psoriasis - p. 177 25. Index - p. 185

No hay muestra disponible

No hay ficha técnica disponible

Descripcion
Descripción

A brand-new title in the field of dermatology, Therapy for Severe Psoriasis provides the ultimate coverage of the treatment options available for today's most serious cases, including biologics and oral therapies. It features discussions of the newest drug therapies, recent FDA-approved biosimilars, and combination approaches to care, while an overview chapter was designed to aid those new to the field in understanding the nuances of difficult-to-treat subtypes of psoriasis. Comprehensive and focused, Therapy for Severe Psoriasis will be a welcome addition to the library of any dermatologist seeking in-depth information on the challenges of this condition.

  • Each of the 16 chapters includes either an in-depth focus on a single therapy or an overview of a unique aspect of psoriasis, including: UVB therapy, methotrexate, acitretin, cyclosporine, apremilast, etanercept, infliximab, adalimumab, ustekinumab, secukinumab, and ixekizumab.
  • Takes an evidence-based approach to hard-to-treat severe psoriasis.
  • Discusses the newest drug therapies (such as ixekizumab), plus recent FDA-approved biosimilars, a topic unique to this particular psoriasis text.
  • Presents combination approaches for instances when standard treatments are not successful.
  • Includes an overview chapter to help beginners understand the nuances of the disorder.

1. Cover image - p. ii 2. Title page - p. ii 3. Table of Contents - p. iii 4. Copyright - p. iii 5. Contributors - p. iii 6. Foreword - p. iii 7. Preface - p. iii 8. List of Tables - p. iii 9. Chapter 1: Overview of Psoriasis - p. iii 10. Chapter 2: Ultraviolet B Phototherapy - p. 13 11. Chapter 3: Psoralen-Ultraviolet Light A Therapy - p. 24 12. Chapter 4: Methotrexate - p. 33 13. Chapter 5: Acitretin - p. 46 14. Chapter 6: Cyclosporine - p. 60 15. Chapter 7: Apremilast - p. 71 16. Chapter 8: Etanercept - p. 81 17. Chapter 9: Infliximab - p. 94 18. Chapter 10: Adalimumab - p. 107 19. Chapter 11: Ustekinumab - p. 124 20. Chapter 12: Secukinumab - p. 134 21. Chapter 13: Ixekizumab - p. 150 22. Chapter 14: Biosimilars - p. 161 23. Chapter 15: Combination Therapies for Psoriasis - p. 168 24. Chapter 16: Investigational Therapies for Psoriasis - p. 177 25. Index - p. 185

Indice
Autores
Muestra

No hay muestra disponible

Ficha Técnica

No hay ficha técnica disponible